Recombinetics is a global thought leader in livestock gene editing and applied technology.

Founded in 2008, RCI is a privately held Minnesota-based biotechnology company that aims at solving the world’s most intractable challenges, from improving human health to sustainably feeding an ever-growing population.

Delivering viable products and generating revenues today, RCI is rapidly growing to broadly commercialize the sale and distribution of its gene-edited animals to the large and growing biomedical and agricultural markets.

Watch this video to learn more about RCI: